Desensitization protocols for vancomycin hypersensitivity

Annals of Pharmacotherapy

Volumn 35, Issue 11, 2001, Pages 1458-1464

  Wazny, L D ^a   Daghigh, B ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Anaphylaxis; Red Man syndrome; Vancomycin

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; ATRACURIUM; BARBITURIC ACID DERIVATIVE; BENZYLISOQUINOLINE DERIVATIVE; CIPROFLOXACIN; CISATRACURIUM; CONTRAST MEDIUM; DALFOPRISTIN; DEXTRAN; DIPHENHYDRAMINE; DOXACURIUM; DOXEPIN; FAMOTIDINE; HYDROCORTISONE; HYDROXYZINE; LINEZOLID; METHYLPREDNISOLONE; MIVACURIUM; NARCOTIC ANALGESIC AGENT; POLYGELINE; PROPOFOL; QUINUPRISTIN; RANITIDINE; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; VANCOMYCIN;

ANAPHYLAXIS; DESENSITIZATION; DRUG HYPERSENSITIVITY; HUMAN; MEDICAL INFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RED MAN SYNDROME; REVIEW; SKIN TEST; TREATMENT FAILURE;

EID: 0034766151     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A002     Document Type: Review

References (44)

1. Prospective evaluation of red man syndrome in patients receiving vancomycin
2. Red man syndrome: Incidence, etiology, and prophylaxis
3. Vancomycin and the RMS: Pharmacodynamics of histamine release
4. Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels
5. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics
6. Anaphylaxis
7. Muscle relaxants and histamine release
8. Allergic reactions to drugs and biologic agents
9. Vancomycin-induced histamine release and "RMS": Comparison of 1- and 2-hour infusions
10. Anaphylactoid reactions to glycopeptide antibiotics
11. Vancomycin anaphylaxis and successful desensitization
12. Hazards of rapid administration of vancomycin
13. Vancomycin and cardiac arrest
14. Antihistamine prophylaxis permits rapid vancomycin infusion
15. Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome
16. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions
17. Vancomycin hypersensitivity: Synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol
18. Desensitization in the management of vancomycin hypersensitivity
19. Anaphylaxis: How to recognize, treat, and prevent potentially fatal attacks
20. Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization
21. Anaphylaxis
22. Diseases of immediate type hypersensitivity
23. Vancomycin skin tests and predication of "RMS" in healthy volunteers
24. Tryptase: A clinical indicator of mast cell - Dependent events
25. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis
26. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
27. Insect-sting challenge in 138 patients: Relation between clinical severity of anaphylaxis and mast cell activation
28. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells
29. The alpha form of human tryptase is the predominant type present in the blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
30. Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis
31. Serum tryptase levels in adverse drug reactions
32. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells
33. Drug allergy
34. Current and future management of infections due to methicillin-resistant staphylococci: The role of quinupristin-dalfopristin
35. Quinupristin - Dalfopristin: An overview
36. Clinical experience with linezolid in a community hospital setting
37. Linezolid
38. Linezolid and reversible myelosuppression
39. Antigen-specific desensitization to prevent allergic reactions to drugs
40. Successful vancomycin desensitization in a patient with end-stage renal disease and anaphylactic shock to vancomycin
41. Desensitization to vancomycin
42. Mast cells and basophils in adverse reactions to drugs used during general anesthesia
43. Histamine release during morphine and fentanyl anesthesia
44. Histamine release by narcotics and muscle relaxants in humans